|
Finding guide for terms in these glossaries
Technologies
map Site
Map
Ultimately, the new genomic and proteomics technologies
are not just about generating reams of disparate bits of data, they aim to
provide a unified view of complex biological systems. The first step in this
process is generating gene networks from gene sequence and expression data. Such
studies do not require new tools as much as sophisticated and comprehensive
approaches to data compilation. Correspondingly, protein pathway studies pull
together data about how changes in protein expression levels modulate the
expression of other proteins in a cascade fashion. In our framework, integration
at the protein level has been extended into systems biology, which can be
described as the integration of genomic, proteomic and metabolic data.
CHI’s Drug Discovery and Development Map
AFM atomic force microscopy: A type of scanning probe microscopy
in which a probe systematically rides across the surface of a sample being
scanned in a raster pattern. The vertical position is recorded as a spring
attached to the probe rises and falls in response to peaks and valleys
on the surface. These deflections produce a topographic map of the sample. MeSH,
1995 Microscopy automation: Needed to industrialize processes, for higher throughput,
greater reliability and often for cost- effectiveness. Related terms: LIMS, robotics
Drug
discovery & development
bioengineering: Rooted in physics, mathematics, chemistry, biology, and the life sciences. It is the application of a systematic, quantitative, and integrative way of thinking about and approaching the solutions of problems important to biology, medical research, clinical proactive, and population studies. The NIH Bioengineering Consortium agreed on the following definition for bioengineering research on biology, medicine, behavior, or health recognizing that no definition could completely eliminate overlap with other research disciplines or preclude variations in interpretation by different individuals and organizations. Integrates physical, chemical, or mathematical sciences and engineering principles for the study of biology, medicine, behavior, or health. It advances fundamental concepts, creates knowledge for the molecular to the organ systems levels, and develops innovative biologics,
materials, processes, implants, devices, and
informatics approaches for the prevention, diagnosis, and treatment of disease, for patient rehabilitation, and for improving health.
NIH, Bioengineering Consortium, 1997 http://www.becon.nih.gov/bioengineering_definition.htm
Bioengineering & Biomaterials
cellular
dielectric spectroscopy: A label-free cell-based technology for drug
discovery. It has been initially applied to pharmacological assessment of cell
surface receptor activity. MDS Sciex http://www.mdssciex.com/products/about%20cds%20new/default.asp?s=1
combinatorial chemistry:
Using a combinatorial process to prepare sets of compounds from sets of
building blocks. [IUPAC Combinatorial Chemistry] Note
that there is not enough matter in the universe to prepare all possible
combinatorial variations. Related terms: combinatorial libraries,
diversity, microtiter plates, molecular diversity, fully
combinatorial, pool/ split Combinatorial
libraries & synthesis disruptive technologies:
Some technologies are improved in a
linear fashion or incrementally. Others truly change the paradigm.
Clayton Christensen writes about these in The Innovator's Dilemma.
What is particularly interesting about Christensen's analysis (based on
data from the disk drive industry) is that he found disruptive technologies
tended to be much cheaper than existing technologies. Existing companies
were quite capable of developing the technologies (and had). What they
couldn't do was figure out how to market them and whether it made sense
to devote sufficient resources to them (which in many cases would not have
been the responsible thing to do.) Related term nonlinear. Business
of biopharmaceuticals
emerging technologies:
enabling technologies:
InSight Pharma Reports The
Human Genome Project taught that evolutionary improvement in existing
technologies (e.g., DNA sequencing) can have a revolutionary impact on science.
The systems approach taken by the Genomes to Life program dictates that existing
technologies must evolve to a high-throughput capability. In addition,
revolutionary technologies need to be developed, incorporating new modes of
robotics and automation as well as advanced information and computing
technologies. Enabling Technologies, DOE Genomes to Life, US http://www.doegenomestolife.org/technology/index.html Frequently cited examples of enabling
technologies for drug discovery and development are combinatorial
chemistry,
high-throughput screening, microarrays, bioinformatics and computational
biology, nanotechnologies, and imaging (including biosensors and
biomarkers) Business
of biopharmaceuticals gene manipulation:
The use of in vitro techniques to produce
DNA molecules containing novel combinations of genes or altered sequences,
and the insertion of these into vectors that can be used for their incorporation
into host organisms or cells in which they are capable of continued propagation
of the modified genes. [IUPAC Biotech] Genetic
Manipulation & Disruption genetic engineering:
Directed modification of the gene complement of a living organism by such techniques as altering the
DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting
cell hybrids, etc. [MeSH, 1989] Related term: recombinant DNA technology.
[IUPAC Compendium] Bioengineering
& Biomaterials
genomic arrays:
Allow toxicologists to look at cellular behavior in a completely new light. In a sense, recording individual gene responses to powerful insults such as alkylating agents was akin to studying the effects of poverty by monitoring a person's bank account - the complete picture is much larger than what is actually being measured. But genomic arrays simultaneously report indicators of multiple dimensions of the cellular response to stimuli. Now, in addition to gaining insight into basic cellular mechanisms of repair, researchers looking at a variety of indicators and responses of toxicity may gain some predictive power regarding individual compounds - and individual humans. Both academic and private laboratories have already begun work on finding
genes that induce protection or sensitivity to toxicants in individual cells and people. [NIEHS News "Arrays cast toxicology in a new light" Environmental Health Perspectives 09 (1), Jan. 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109-1/niehsnews.html
Microarray categories
genomic technologies: One of the primary reasons for the success of the Human
Genome Project has been the development and use of high- throughput strategies
for data generation, and the placement of the data immediately in the public
domain. Most of the sequence data, the underlying maps and the sequence
assemblies were generated through the use of large- scale automated processes.
Now, methods such as sequence analysis of whole genomes, DNA microarray
technology and mass spectrometry have been or are being developed as high-
throughput approaches for additional types of genomic analyses, such as
determining the parameters of gene expression or the location of gene products
by the thousands at a time instead of individually. High- throughput methods to
determine the location of cis- regulatory elements and, to a lesser extent,
other sequence elements, are also beginning to be developed. However, at
present, there is no single approach or compilation of approaches that can
accurately and efficiently identify every sequence feature in genomic DNA.
Determination of all Functional Elements in Human DNA, Release date, NHGRI,
February 21, 2003 RFA: HG-03-003 http://grants1.nih.gov/grants/guide/rfa-files/RFA-HG-03-003.html Genomics
hyphenated techniques:
Usually involves a combination of chromatography
and/ or mass spectrometry, NMR or other spectroscopy technologies.
Laser Capture
Microdissection LCM: Cell
biology mass spectrometry:
Can be used to both measure and analyze molecules under study. It involves introducing enough energy into a
target molecule to cause its ionization and disintegration. The resulting fragments are then analyzed, based on the
mass/ charge ratio to produce a "molecular fingerprint." A significant force behind progress in proteomics
.Mass
Spectrometry
microarray:
Tool for studying how large numbers of genes interact
with each other and how a cell’s regulatory networks control vast batteries
of genes simultaneously. Uses a robot to precisely apply tiny droplets
containing functional DNA to glass slides. Researchers then attach fluorescent
labels to DNA from the cell they are studying. The labeled probes are allowed
to bind to cDNA strands on the slides. The slides are put into a scanning
microscope to measure … how much of a specific DNA fragment is present.
[NHGRI]
Roger Brent has compared microarrays to the telescope or microscope
because they enable the observer to see what was previously unobservable.
Microarrays & protein chips
miniaturization:
Desirable for many technologies for overall
cost reduction (including reduction in the amount of reagents and analytes).
Important to remember that building space is often the least available
and most expensive component of a laboratory budget. Nanoscience
& Miniaturization molecular
imaging: Molecular imaging multiplex: A sequencing approach that uses several pooled samples,
greatly increasing sequencing speed. [DOE] Originally a 19th century
telecommunications (telegraph) term. Gene
amplification & PCR NMR Nuclear Magnetic Resonance:
A technology for
protein
structure determination. NMR generally gives a lower- resolution structure
than X-ray crystallography does, but it does not require crystallization.
NMR
& X-ray crystallography nanodelivery:
Targeted therapy offers the promise of creating drugs
that by the specificity of their design and delivery make them both more
effective and less toxic. Multifunctional devices offer novel capabilities,
including the possibility of delivering a detection, imaging agent, and drug in
one vehicle. This creates the unique advantage of being able to give
distribution data and traceability through the use of one agent, that can in
tandem detect, address, and monitor disease. This functionality can be leveraged
to deliver multiple combinations of drugs by extended release. Nanotechnology
promises to create a break-through class of imaging agents that offer distinct
advantages and can be used for the early detection and diagnosis of disease.
Diagnostic molecules have the potential to act as biomarkers in drug development
and diagnostics, and can be used in the imaging of cancer in living subjects.
Nanoscience
& miniaturization nanoscience:
Nanoscience is primarily the extension of existing sciences into the realms of the extremely small
(nanomaterials, nanochemistry, nanobio, nanophysics, etc.) while nanoengineering represents the extension of the engineering fields into the nano- scale realm
(nanofabrication, nanodevices, etc.). [Mnemosyne Mnews 21 (3) January 2001 " The Nanotechnology Initiative and Future Electronics" Presentation by Gail J. Brown, Air Force Research Laboratory, Wright-Patterson Air Force Base, Nov.16, 2000]
http://users.erinet.com/3277/Mnemosyne%20Mnews%20Jan%2001.pdf Nanoscience
& miniaturization next
generation genomic technologies: Technological
advances are now enabling faster and cheaper mapping of DNA/RNA allowing
genomic comparisons and accelerating genomic discoveries. X Gen Congress March 15-19, 2010 • San Diego, CA Program | Register | Download Brochure
nonlinear:
Advances in genomic technologies are a mix of incremental
improvements to existing technologies (linear) and occasionally, a truly
new paradigm or breakthrough. Related terms: disruptive technologies,
emerging technologies, complex. Genomics
PCR Polymerase Chain Reaction:
In vitro method for producing large amounts of
specific DNA or RNA fragments of defined length and sequence from small amounts
of short oligonucleotide flanking sequences (primers). The essential steps
include thermal denaturation of the double- stranded target
molecules, annealing of the primers to their complementary sequences, and
extension of the annealed primers by enzymatic synthesis with DNA polymerase.
The reaction is efficient, specific, and extremely sensitive. Uses for the
reaction include disease diagnosis, detection of difficult to isolate pathogens,
mutation analysis, genetic
testing, DNA sequencing,
and analyzing evolutionary relationships. MeSH, 1991
Demand for
genomic and gene expression analysis continues. However, nucleic acid isolation
and purification is one of the most technically challenging and labor-intensive
procedures performed in any laboratory, whether for biodefense, drug discovery,
or diagnostics. Whatever technology is selected, success depends on a balanced
combination of good experimental design, sample preparation, primer/probe
design, amplification, detection, and analysis, as well as the selection of
equipment and reagents.
Gene
amplification & PCR
RNAi
RNA interference: Genetic
manipulation & disruption recombinant DNA technology: A body of techniques for cutting apart and splicing together different pieces of
DNA. When segments of foreign DNA are transferred into another cell or organism, the substance for which they code may be produced along with substances coded for by the native genetic material of the cell or organism. Thus, these cells become "factories" for the production of the
protein coded for by the inserted DNA.
[NIGMS] Related terms: biotechnology, gene manipulation, genetic
engineering
Genetic Manipulation & Disruption robust: A process which is
relatively insensitive to human foibles and variables in the way (for example,
an assay) is carried out, a statistical term.
Algorithms sample prep:
Extracting, creating and keeping samples and templates of highest quality
are the key factors for producing high-throughput data of optimal quality. For
successful data output, state of the art information on the rapidly emerging
integration of technologies is necessary. Bioprocessing sequencing:
(proteins, nucleic acids) Analytical procedures for the determination of the order of
amino acids in a polypeptide chain or of nucleotides in a
DNA or RNA molecule. [IUPAC Compendium]
Sequencing sexy technologies: What makes technologies sexy?
It seems to be a combination of being new, innovative, challenging, affording
clever people a chance to learn new skills (and demonstrate how competitive
and bright they are) and expensive (or otherwise unavailable to everyone).
A quick search of the web identifies high- speed computers, robotics,
nanotechnology,
HDTV, Java, wireless communications and biomaterials as "sexy" by
some criteria. I'd be interested to hear other interpretations and
nuances of this class of technologies. Are there significant differences in what are sexy
technologies to biologists, businesspeople, chemists, computer
scientists and others? Business of
biopharmaceuticals single molecule detection:
Recent advances in optical imaging and biomechanical techniques have demonstrated that it is possible to
make observations on the dynamic behavior of single molecules, to determine mechanisms of action at the level of an individual molecule, and to explore
heterogeneity among different molecules within a population. These studies have the potential to provide fundamentally new information about biological
processes and are critical for a better understanding of cellular function. ...
Single molecule methods are likely to lead to significant advances in understanding
molecular movement, dynamics, and function. NIGMS, NICDC, NHGRI, Single
Molecule Detection and Manipulation, Feb. 12, 2001 http://grants.nih.gov/grants/guide/pa-files/PA-01-049.html
Ultrasensitivity standards:
Bioinformatics ,
Microarrays
synchrotrons:
Devices for accelerating protons or electrons in
closed orbits where the accelerating voltage and magnetic field strength
varies (the accelerating voltage is held constant for electrons) in order
to keep the orbit radius constant. MeSH, 1993 NMR
& X-ray crystallography
target validation technologies:
A number of technologies including downregulation
of gene expression
(gene knockdown, antisense, ribozymes and zinc finger proteins), protein
inhibition (phage libraries and antibodies), cellular assays, chemical genetics,
and combinatorial biology
are linked with target validation.
The integration of various technologies is another challenge Drug
targets
technology
platforms:
technology
validation: This Center offers
technology validation services to a broad range of Commercial Investigators,
from emerging Biotechs to large Pharma and Instrument Manufacturers. In the TVC,
technology validation is defined as confirmation of the appropriateness,
effectiveness, robustness, accuracy, and reproducibility of a particular
technology when applied to a specific task. Successful validation is defined by
technical and statistical parameters established in advance by INCAPS in
consultation with the customer. Indiana Centers for Applied Protein
Sciences, http://www.indianacaps.com/about/centers.shtml
tissue
models: Cells, tissues, and organs function in a 3-D
environment. Utilization of 3-D in vitro tissue models can help validate
functionally new targets and pre- selected hits more efficiently then immediate in
vivo testing. Bioengineering
& Biomaterials
zeptomole:
10–21 mole. One- sextillionth. Ultrasensitivity
Bibliography
HSTAT Health Services Technologies Assessment Text,
National Library of Medicine http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat
Alpha
glossary index
How
to look for other unfamiliar terms
IUPAC definitions are reprinted with the permission of the International
Union of Pure and Applied Chemistry.
|